RIPK3 and neoplasm: Because Ripk3−/− mice exhibited higher tumor burdens accompanied with enhanced production of cytokines and chemokines (Figure 3), we next hypothesized that RIPK3 suppresses tumor development and progression by negatively regulating inflammatory mediators with pro-tumorigenic effects.